BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 27852589)

  • 1. Effects of the P-Selectin Antagonist Inclacumab on Myocardial Damage After Percutaneous Coronary Intervention According to Timing of Infusion: Insights From the SELECT-ACS Trial.
    Stähli BE; Gebhard C; Duchatelle V; Cournoyer D; Petroni T; Tanguay JF; Robb S; Mann J; Guertin MC; Wright RS; L L'Allier P; Tardif JC
    J Am Heart Assoc; 2016 Nov; 5(11):. PubMed ID: 27852589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of the P-selectin antagonist inclacumab on myocardial damage after percutaneous coronary intervention for non-ST-segment elevation myocardial infarction: results of the SELECT-ACS trial.
    Tardif JC; Tanguay JF; Wright SR; Duchatelle V; Petroni T; Grégoire JC; Ibrahim R; Heinonen TM; Robb S; Bertrand OF; Cournoyer D; Johnson D; Mann J; Guertin MC; L'Allier PL
    J Am Coll Cardiol; 2013 May; 61(20):2048-55. PubMed ID: 23500230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ST-segment elevation on intracoronary electrocardiogram after percutaneous coronary intervention is associated with worse outcome in patients with non-ST-segment elevation myocardial infarction.
    Hishikari K; Kakuta T; Lee T; Murai T; Yonetsu T; Isobe M
    Catheter Cardiovasc Interv; 2016 Mar; 87(4):E113-21. PubMed ID: 26152334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Timing of Loading Dose of Atorvastatin in Patients Undergoing Percutaneous Coronary Intervention for Acute Coronary Syndromes: Insights From the SECURE-PCI Randomized Clinical Trial.
    Lopes RD; de Barros E Silva PGM; de Andrade Jesuíno I; Santucci EV; Barbosa LM; Damiani LP; Nakagawa Santos RH; Laranjeira LN; Dall Orto FTC; Beraldo de Andrade P; de Castro Bienert IR; Alexander JH; Granger CB; Berwanger O
    JAMA Cardiol; 2018 Nov; 3(11):1113-1118. PubMed ID: 30264159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of intravenous vitamin C infusion on periprocedural myocardial injury for patients undergoing elective percutaneous coronary intervention.
    Wang ZJ; Hu WK; Liu YY; Shi DM; Cheng WJ; Guo YH; Yang Q; Zhao YX; Zhou YJ
    Can J Cardiol; 2014 Jan; 30(1):96-101. PubMed ID: 24365194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracoronary ST-segment shift soon after elective percutaneous coronary intervention accurately predicts periprocedural myocardial injury.
    Balian V; Galli M; Marcassa C; Cecchin G; Child M; Barlocco F; Petrucci E; Filippini G; Michi R; Onofri M
    Circulation; 2006 Oct; 114(18):1948-54. PubMed ID: 17060382
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Remote ischemic post-conditioning of the lower limb during primary percutaneous coronary intervention safely reduces enzymatic infarct size in anterior myocardial infarction: a randomized controlled trial.
    Crimi G; Pica S; Raineri C; Bramucci E; De Ferrari GM; Klersy C; Ferlini M; Marinoni B; Repetto A; Romeo M; Rosti V; Massa M; Raisaro A; Leonardi S; Rubartelli P; Oltrona Visconti L; Ferrario M
    JACC Cardiovasc Interv; 2013 Oct; 6(10):1055-63. PubMed ID: 24156966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: the Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction (METOCARD-CNIC) trial.
    Ibanez B; Macaya C; Sánchez-Brunete V; Pizarro G; Fernández-Friera L; Mateos A; Fernández-Ortiz A; García-Ruiz JM; García-Álvarez A; Iñiguez A; Jiménez-Borreguero J; López-Romero P; Fernández-Jiménez R; Goicolea J; Ruiz-Mateos B; Bastante T; Arias M; Iglesias-Vázquez JA; Rodriguez MD; Escalera N; Acebal C; Cabrera JA; Valenciano J; Pérez de Prado A; Fernández-Campos MJ; Casado I; García-Rubira JC; García-Prieto J; Sanz-Rosa D; Cuellas C; Hernández-Antolín R; Albarrán A; Fernández-Vázquez F; de la Torre-Hernández JM; Pocock S; Sanz G; Fuster V
    Circulation; 2013 Oct; 128(14):1495-503. PubMed ID: 24002794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optical Coherence Tomography to Optimize Results of Percutaneous Coronary Intervention in Patients with Non-ST-Elevation Acute Coronary Syndrome: Results of the Multicenter, Randomized DOCTORS Study (Does Optical Coherence Tomography Optimize Results of Stenting).
    Meneveau N; Souteyrand G; Motreff P; Caussin C; Amabile N; Ohlmann P; Morel O; Lefrançois Y; Descotes-Genon V; Silvain J; Braik N; Chopard R; Chatot M; Ecarnot F; Tauzin H; Van Belle E; Belle L; Schiele F
    Circulation; 2016 Sep; 134(13):906-17. PubMed ID: 27573032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative prognostic value of postprocedural creatine kinase myocardial band and high-sensitivity troponin T in patients with non-ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention.
    Ndrepepa G; Colleran R; Braun S; Xhepa E; Hieber J; Cassese S; Fusaro M; Kufner S; Laugwitz KL; Schunkert H; Kastrati A
    Catheter Cardiovasc Interv; 2018 Feb; 91(2):215-223. PubMed ID: 28500730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apoptosis kinetics at reperfusion period in patients with acute ST-Segment Elevation Myocardial Infarction undergoing primary percutaneous coronary intervention and treated with thrombolytic therapy.
    Gultekin N; Bulut G; Kucukates E; Yildiz A; Kocas C; Bulut L
    J Pak Med Assoc; 2016 Jul; 66(7):808-14. PubMed ID: 27427127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gradual Versus Abrupt Reperfusion During Primary Percutaneous Coronary Interventions in ST-Segment-Elevation Myocardial Infarction (GUARD).
    Sezer M; Escaned J; Broyd CJ; Umman B; Bugra Z; Ozcan I; Sonsoz MR; Ozcan A; Atici A; Aslanger E; Sezer ZI; Davies JE; van Royen N; Umman S
    J Am Heart Assoc; 2022 May; 11(10):e024172. PubMed ID: 35574948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trimetazidine administration minimizes myocardial damage and improves left ventricular function after percutaneous coronary intervention.
    Labrou A; Giannoglou G; Zioutas D; Fragakis N; Katsaris G; Louridas G
    Am J Cardiovasc Drugs; 2007; 7(2):143-50. PubMed ID: 17503885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abciximab in patients with acute coronary syndromes undergoing percutaneous coronary intervention after clopidogrel pretreatment: the ISAR-REACT 2 randomized trial.
    Kastrati A; Mehilli J; Neumann FJ; Dotzer F; ten Berg J; Bollwein H; Graf I; Ibrahim M; Pache J; Seyfarth M; Schühlen H; Dirschinger J; Berger PB; Schömig A;
    JAMA; 2006 Apr; 295(13):1531-8. PubMed ID: 16533938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early Use of N-acetylcysteine With Nitrate Therapy in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Segment-Elevation Myocardial Infarction Reduces Myocardial Infarct Size (the NACIAM Trial [N-acetylcysteine in Acute Myocardial Infarction]).
    Pasupathy S; Tavella R; Grover S; Raman B; Procter NEK; Du YT; Mahadavan G; Stafford I; Heresztyn T; Holmes A; Zeitz C; Arstall M; Selvanayagam J; Horowitz JD; Beltrame JF
    Circulation; 2017 Sep; 136(10):894-903. PubMed ID: 28634219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colchicine to Prevent Periprocedural Myocardial Injury in Percutaneous Coronary Intervention: The COPE-PCI Pilot Trial.
    Cole J; Htun N; Lew R; Freilich M; Quinn S; Layland J
    Circ Cardiovasc Interv; 2021 May; 14(5):e009992. PubMed ID: 34003667
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of Percutaneous Coronary Intervention on Death and Myocardial Infarction Stratified by Stable and Unstable Coronary Artery Disease: A Meta-Analysis of Randomized Controlled Trials.
    Chacko L; P Howard J; Rajkumar C; Nowbar AN; Kane C; Mahdi D; Foley M; Shun-Shin M; Cole G; Sen S; Al-Lamee R; Francis DP; Ahmad Y
    Circ Cardiovasc Qual Outcomes; 2020 Feb; 13(2):e006363. PubMed ID: 32063040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Invasive Management Strategies and Antithrombotic Treatments in Patients With Non-ST-Segment-Elevation Acute Coronary Syndrome in China: Findings From the Improving CCC Project (Care for Cardiovascular Disease in China).
    Yang Q; Wang Y; Liu J; Liu J; Hao Y; Smith SC; Huo Y; Fonarow GC; Ma C; Ge J; Taubert KA; Morgan L; Guo Y; Wang W; Zhou Y; Zhao D;
    Circ Cardiovasc Interv; 2017 Jun; 10(6):. PubMed ID: 28606999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardioprotective Effects of Intracoronary Morphine in ST-Segment Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention: A Prospective, Randomized Trial.
    Gwag HB; Kim EK; Park TK; Lee JM; Yang JH; Song YB; Choi JH; Choi SH; Lee SH; Chang SA; Park SJ; Lee SC; Park SW; Jang WJ; Lee M; Chun WJ; Oh JH; Park YH; Choe YH; Gwon HC; Hahn JY
    J Am Heart Assoc; 2017 Apr; 6(4):. PubMed ID: 28373244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic and Practical Validation of Current Definitions of Myocardial Infarction Associated With Percutaneous Coronary Intervention.
    Tricoci P; Newby LK; Clare RM; Leonardi S; Gibson CM; Giugliano RP; Armstrong PW; Van de Werf F; Montalescot G; Moliterno DJ; Held C; Aylward PE; Wallentin L; Harrington RA; Braunwald E; Mahaffey KW; White HD
    JACC Cardiovasc Interv; 2018 May; 11(9):856-864. PubMed ID: 29747915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.